News & Events
Optellum’s lung cancer prediction AI is clinically validated in Thorax
The Optellum artificial intelligence prediction model has been demonstrated to outperform the best currently used model. Prediction of the likelihood ...
New Appointments Strengthen Leadership Team
Optellum has strengthened leadership team to support the commercialisation and clinical validation of its first product, and the development of ...
Optellum co-founder helps start the world’s first AI university.
Optellum Chairman & co-founder, Prof. Sir Michael Brady FRS (center), is named the founding Board of Trustees member, and the ...
Optellum at AI@Oxford Conference
Optellum Founder and Chief Science & Technology Officer will share the lessons learned by Optellum in enabling early lung cancer ...
Optellum Science at the World Conference on Lung Cancer
IASLC World Conference on Lung Cancer, the world's premier event for physicians and scientists advancing the fight against world's deadliest ...
Optellum selected for TMCx Accelerator at the world’s largest medical complex
The Optellum team is excited to be selected for the 2019 Digital Health Accelerator Cohort at TMCx, to be spend ...
Oxford secures £17.5 million to lead the world in imaging AI, in partnership with Optellum
Optellum team and advisors took the lead role in preparing the winning bid, with Optellum Chairman, Prof Sir Michael Brady ...
Optellum Science at the IASLC World Conference on Lung Cancer
This week Optellum has been highlighted in three presentations at the IASLC World Conference on Lung Cancer in Toronto, Canada ...
Prof Sam Janes joins Optellum Medical Advisory Board
Optellum welcomes an internationally renowned physician and scientist in early lung cancer diagnosis and treatment, Dr. Sam Janes MD, to join ...
Meet Optellum at the ATS 2018 Congress
Join us at the American Thoracic Society 2018 Congress in San Diego, North America's premier congress for pulmonary medicine, from ...
US National Lung Screening Trial PI visits Optellum
Optellum is delighted to welcome Dr. Christine Berg, the co-Principal Investigator of the US National Lung Screening Trial (NLST), the ...
Leo Grady joins Optellum’s Scientific Advisory Board
Optellum Scientific Advisory Board welcomes Leo Grady, an internationally recognized expert in healthcare machine learning and building medical imaging Software-as-a-Service ...
